Login / Signup

Design of enamides as new selective monoamine oxidase-B inhibitors.

Fathima Sahla KavullyJong Min OhSanal DevSwafvan KaipakasseriAshique PalakkathondiAjeesh VengamthodiRinshana Fathima Abdul AzeezAnna Rita TondoOrazio NicolottiHoon KimBijo Mathew
Published in: The Journal of pharmacy and pharmacology (2020)
These results encourage further studies on the enamide scaffold as potential drug candidates for the treatment of Alzheimer's and Parkinson's diseases.
Keyphrases
  • cognitive decline
  • emergency department
  • risk assessment
  • case control
  • replacement therapy